U-Blot® Research Grade rocduntatugCat. No. WA3472Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade rocduntatugCat. No. WA3472
U-Blot® Research Grade RocatinlimabCat. No. WA3471
U-Blot® Research Grade RobatumumabCat. No. WA3470
U-Blot® Research Grade RivabazumabCat. No. WA3469
U-Blot® Research Grade RituximabCat. No. WA3468
U-Blot® Research Grade RituximabCat. No. WA3467
U-Blot® Research Grade risvutatugCat. No. WA3466
U-Blot® Research Grade RisankizumabCat. No. WA3465
U-Blot® Research Grade RipertamabCat. No. WA3464
U-Blot® Research Grade Rinvecalinase AlfaCat. No. WA3463
U-Blot® Research Grade rinvaterceptCat. No. WA3462
U-Blot® Research Grade rinumafusp alfaCat. No. WA3461